B2B ad examples
6,645 B2B ads are live on LinkedIn right now, from 2,070 companies. Browse real ones, filtered by industry.
- InstahelpSince 23 Oct 2026
Kein Apfel der Welt hilft, wenn Mitarbeitende nachts wach liegen, weil Deadlines, Konflikte im Team oder private Sorgen keine Ruhe lassen. Obstkorb und Co. sind nett. Aber mentale Gesundheit braucht mehr als klassische Benefits. Sie braucht echte Unterstützung. Mit Instahelp gibst du deinem Team Zugang zu psychologischer Online-Beratung: ✔️ Über 400 qualifizierte Psycholog:innen statt Chatbots ✔️ Erstkontakt zur Terminvereinbarung binnen 24 Stunden ✔️ Vertraulich, flexibel und auch außerhalb der Arbeitszeiten verfügbar ✔️ Einfach eingeführt, mit persönlicher Unterstützung für HR Weil gesunde Teams mehr brauchen als gesunde Snacks. 👉 Jetzt unverbindlich anfragen
- Evaluate LtdSince 22 Oct 2026
With rapid market growth, major patent expirations and innovative therapies reshaping the competitive landscape, the race for immunology leadership is on. In the latest episode of Evaluate Spotlight, discover which companies are positioned to lead through 2032, where dealmaking is heading and how precision approaches are opening new opportunities.
- Evaluate LtdSince 22 Oct 2026
AI may be everywhere in commercial pharma, but defensible answers are much harder to find. While most teams are testing general-purpose tools, these platforms often lack the curated data, pharmaceutical context and traceability needed to support decisions with real commercial consequences. Explore the infographic to see what separates AI built for demos from AI built for decisions.
- FOPI - Die forschenden PharmaunternehmenSince 23 Oct 2026
#𝗕𝗿𝘂𝘀𝘁𝗸𝗿𝗲𝗯𝘀 𝗶𝘀𝘁 𝗻𝗶𝗰𝗵𝘁 𝗴𝗹𝗲𝗶𝗰𝗵 𝗕𝗿𝘂𝘀𝘁𝗸𝗿𝗲𝗯𝘀. Brustkrebs kann sehr unterschiedlich verlaufen. Entscheidend ist nicht nur, wie weit sich die Erkrankung ausgebreitet hat, also ob sich schon Metastasen gebildet haben, sondern auch, welche biologischen Merkmale der Tumor aufweist. Eine genaue Diagnose schafft die Grundlage, um die Erkrankung besser zu verstehen und die Behandlung individuell auszurichten. Für die passende Behandlungsplanung zählt deshalb das Gesamtbild: die Erkrankung, ihre individuellen Merkmale und die persönliche Situation der betroffenen Person. Ebenso wichtig ist der Blick auf das, was der Patientin wichtig ist – Zeit mit der Familie, Beruf und Lebensqualität. Die #Gilead-Initiative „more – Momente im Leben“ rückt persönliche Augenblicke von Menschen mit metastasiertem Brustkrebs in den Blick. Im #Brustkrebsmonat Oktober nehmen wir diesen Gedanken mit: Medizinischer Fortschritt muss beides im Blick behalten – die Erkrankung und die Bedürfnisse jedes einzelnen Menschen. Dieser Beitrag wurde von Gilead Sciences unterstützt. Bilder: Künstlerin Eva Beresin „Die Freude am Augenblick nimmt mir die Angst vor der Vergänglichkeit.” Künstlerin Natia Kalandadze „Geborgenheit, Wärme, Schutz und bedingungslose Liebe ... Unendlichkeit. Da gibt es keine Grenzen, keine Nationalität, kein Alter. Diese Kraft kann Berge verschieben und macht alles möglich, fast alles!” QUELLEN: Österreichisches Gesundheitsportal, Brustkrebs https://lnkd.in/dKcQUbCU US National Cancer Institute, Biomarker bei Brustkrebs https://lnkd.in/dZa5AwHr Statistik Austria, Krebserkrankungen 2024 https://lnkd.in/dHdR4ZGh Gilead, Initiative more – Momente im Leben https://lnkd.in/evGwEvka
- Hospital Santa Catarina - PaulistaRecorded 27 Oct 2026
Cuidado especializado para quem merece atenção em todos os detalhes. No Pronto Atendimento do Hospital Santa Catarina – Paulista, pessoas idosas contam com estrutura preparada e fluxo dedicado para oferecer atendimento ágil, seguro e humanizado diante de situações de urgência e emergência. Em casos como quedas e suspeitas de fratura de fêmur ou quadril, a rapidez na avaliação e no diagnóstico é fundamental. Por isso, contamos com protocolo ágil de atendimento ortopédico, equipe treinada para uma triagem humanizada e manejo de pacientes com maior fragilidade clínica. Além de geriatra e enfermeira navegadora, que possibilitam um atendimento especializado com fluxo de seguimento ambulatorial, para tratamento e promoção de saúde, visando o envelhecimento saudável. Confira nossos principais diferenciais: • Boxes individualizados, que proporcionam mais privacidade e conforto para a avaliação especializada de pacientes 80+ e idosos frágeis. • Espaço para acompanhante, valorizando a presença da família durante o atendimento; • Geriatra no PA para avaliação especializada de pacientes 80+ e idosos frágeis; • Enfermeira navegadora acompanha toda a jornada assistencial, agilizando diagnósticos, exames e encaminhamentos necessários, mesmo após a alta do Pronto Atendimento, contribuindo para maior resolutividade, segurança e continuidade do cuidado; • Exames de imagem com suporte imediato, contribuindo para uma avaliação mais rápida; • UTI qualificada, para os casos que necessitam de cuidados intensivos. Neste Dia Internacional das Pessoas Idosas, reforçamos nosso compromisso com um cuidado que une agilidade, segurança, respeito e humanização. Hospital Santa Catarina – Paulista 120 anos de saúde no coração de São Paulo #HospitalSantaCatarinaPaulista #ProntoAtendimento #Idoso #CuidadoSeguro
- Hospital Santa Catarina - PaulistaRecorded 27 Oct 2026
Dores de cabeça, vômitos, sonolência, quedas e mudanças de comportamento podem gerar dúvidas e preocupação entre pais e responsáveis. Esses foram alguns dos pontos abordados pelo Dr. Sérgio Cavalheiro - RQE 47861, neurocirurgião pediátrico do Hospital Santa Catarina - Paulista, em entrevista à Rádio Disney Brasil. Durante a conversa, ele explicou quais sinais merecem atenção, como é feita a investigação e em quais situações uma cirurgia pode ser considerada. Assista à entrevista completa no YouTube: https://lnkd.in/dhJdyDUq #HospitalSantaCatarinaPaulista #NeurocirurgiaPediátrica #Pediatria
- InovivSince 24 Oct 2026
Your go or no-go call is only as good as your standard. Ours are matched heavy and light pairs, built for absolute quantification.
- SubsaltRecorded 27 Oct 2026
Quality wants 30-day readmissions after TEAM episodes. Marketing wants to know if last quarter’s campaign moved new-patient volume. Neither question needs a patient’s name, but both teams make data requests that will sit for months before they get answers because of HIPAA privacy laws. Subsalt lets both teams ask and get answers instantly, without touching PHI.
- IlluminaSince 23 Oct 2026
From the lab bench to global impact, innovation is built through the collective contributions of people who are united by purpose. Together, we're advancing the science that helps improve human health.
- Future FieldsSince 22 Oct 2026
Expressing a herbicide tolerance trait is only half the battle, producing enough active protein is where pipelines stall. This latest technical article explores: 🟢 Protein supply gaps: Moving past plant extraction limits to secure regulatory test material. 🟢 Herbicide tolerance trait classes: Roles and tolerance pathways across major commercial enzymes. 🟢 Biomanufacturing hurdles: Highlighting solubility, assembly, and cofactor challenges in conventional hosts. ➡️ Explore the full article here 👇
- Foundation MedicineSince 25 Oct 2026
With 12 pieces of research being presented, including two rapid oral presentations, our team is looking forward to joining the international oncology community at #ESMO26! Come learn more about Foundation Medicine and how we are helping to advance precision medicine through our high-quality tests and services. Explore our accepted research: https://lnkd.in/en5443jp/?utm_campaign=Boost_Post_WebsiteVisits_Oct21,2026&utm_source=linkedin&utm_medium=paid&utm_id=1236098816&hsa_acc=510184245&hsa_cam=1236098816&hsa_grp=917089136&hsa_ad=1655300106&hsa_net=linkedin&hsa_ver=3
- headspaceRecorded 27 Oct 2026
If you’re 18-25 and trying to figure out your next professional move, headspace Career Mentoring is here to bridge the gap.
- insitroSince 22 Oct 2026
Forbes named me one of its 250 Greatest Living American Optimists this week, which prompted a useful question: what, exactly, am I optimistic about? Quite a lot. I’m optimistic about science because our ability to observe the world keeps improving. We can measure phenomena that were invisible to us a generation ago, run experiments at extraordinary scale, and replace intuition with evidence more quickly and precisely than before. I’m optimistic about AI because we are still early in discovering what it can do beyond the digital world. I am most excited about bringing computation and experimentation together to understand complex systems that today are largely illegible to both human and machine intelligence. Human biology is the example I care most about. Biology continually surprises us, and the only definitive experiment is the one performed in a human being. The information we need often does not exist until we build the experiments capable of revealing it. AI is very good at connecting dots, but it cannot connect dots that have never been measured, and measuring them is a lot of work. We now have the technology to collect better measurements, generate stronger causal evidence, and build more powerful models from both. That lets us retire weak hypotheses before they reach patients and choose interventions with more confidence. Over time, it can make drug discovery more predictable. The well of human biology is very, very deep. But we do not need to reach the bottom before we start delivering value to patients. I see reasons for optimism in the work immediately ahead of us too: our first programs at insitro moving toward the clinic in MASH, ALS and dry AMD; what we will learn with our new collaborators at AstraZeneca in MASH and cardiomyopathies; and what becomes possible when people from very different fields bring different ways of seeing to the same hard problem. There is plenty in the world that warrants concern. There is also more scientific capability and computational power available to us than at any point in history. It is an honor to be on this list alongside people who have spent their careers investing time, talent and conviction in possibilities that did not yet exist. I am most optimistic about changing the outcome for the patients who are waiting for all of us to get this right. https://lnkd.in/dqZwKPJq
- insitroSince 22 Oct 2026
insitro is proud to announce that biotech companies in the Lilly TuneLab™ network can now deploy advanced machine learning models built by insitro with Eli Lilly and Company (Lilly) to predict in vitro and, critically, in vivo properties of small molecules — representing collective progress advancing the field of AI drug discovery on behalf of patients. We're discussing the news live at SF Tech Week today, where Mary Rozenman, PhD, insitro CFO and CBO, joins Aliza Apple, PhD, Vice President of Catalyze360 AI/ML and Global Head of Lilly TuneLab, at the a16z Bio + Health & Lilly TuneLab biotech breakfast. In advance of the discussion, Mary explained, “We built insitro to make biology an AI problem, with scaled data and models at the frontier. Our in-house data scaling helps us predict which biology we should target to impact disease in vivo. Today’s announcement with Lilly takes the next step. Now we’re predicting how a molecule will behave in vivo so we can make better decisions earlier in R&D by trading upfront compute for downstream conviction. We are thrilled to ship these models on TuneLab to enable this way of working across their ecosystem.” Trained on multi-species preclinical data that Lilly generated over decades of research from hundreds of thousands of unique molecules, the models offer a powerful alternative to today’s industry standard method of extrapolation from in vitro assays, providing an enterprise-grade capability traditionally available only to organizations with the scale to generate such data volumes themselves. The models will be updated as the dataset continues to expand. "The question of a molecule's in vivo behavior has been an empirical question, answered experimentally, slowly, one compound at a time. These models make it a computational question first," said Daphne Koller, PhD, founder and CEO of insitro. The in vivo PK models are a critical component of our TherML™ platform for small molecule discovery, alongside machine learning and physics-based in silico screening, affinity models powered by proprietary DNA-encoded libraries, and an active-learning medicinal chemistry engine. → Read our official announcement: https://lnkd.in/gzdTa8UF → Learn more about how the models work: https://lnkd.in/gGmVmvRi #SFTechWeek #AI #ML #LillyTuneLab #drugdiscovery
- headspaceRecorded 27 Oct 2026
If you’re 18-25 and trying to figure out your next professional move, headspace Career Mentoring is here to bridge the gap.
- 's Heeren LooSince 22 Oct 2026
Zorgvraag of calamiteit? Jij houdt de koers vast in complexe situaties. Word ANW-coördinator in Noordwijk en Zuid-Holland.
- Merck Life ScienceSince 22 Oct 2026
Watch how our team at the Schaffhausen Lipids Center of Excellence masters custom technical challenges while delivering high quality lipids.
- 's Heeren LooSince 22 Oct 2026
Ben jij de collega die we kunnen bellen als het spannend wordt? Maak het verschil bij 's Heeren Loo in Noordwijk en Zuid-Holland.
- Smart Facility SoftwareRecorded 27 Oct 2026
Mobile Cleaning Inspection App. No paper, no data re-entry. Select rooms to inspect by assignment, floor, department, and more. Monitor each cleaning step — get a clear picture of successes and places where your team requires more training. View results immediately with built-in or custom charts. See how it works. https://lnkd.in/ea4zW29s
- FibroBiologics (Nasdaq: FBLG)Recorded 27 Oct 2026
The thymus is a small organ located behind the breastbone, but its role in immune development is significant. Developing T cells mature within the thymic environment, where they develop the receptors that help the immune system recognize a wide range of potential threats. The challenge is that thymic function naturally declines with age. For FibroBiologics, understanding that process is central to a broader research question: how might thymic biology help us better understand immune aging and longevity? The immune system is not simply about strength. It also depends on education. NASDAQ: FBLG
- Flourish ResearchRecorded 27 Oct 2026
In obesity trials, enrollment is only half the job. Long treatment periods test patient retention strategies. Flourish Research brings proven recruitment and retention, plus experienced cardiometabolic PIs, across a wholly-owned U.S. site network.
- Health AdvocateRecorded 27 Oct 2026
Planning significant benefits changes for 2027? New plans, vendors, and programs can create more choice, but they can also create confusion. When employees don't know where to turn, what's covered, or how to make informed healthcare decisions, even the best benefits strategy can fall short. Health Advocate helps create one connected experience that simplifies navigation, delivers personalized support, and helps employees get the most from their benefits. Learn how we can help make change easier: https://lnkd.in/eKtA7a7n
- CONNECT CommunitiesRecorded 27 Oct 2026
There's a meaningful story behind the new welcome sign at CONNECT Saanich Peninsula. 💙 Learn more about the carving, its symbolism, and the community celebration in our latest blog. 🔗 https://lnkd.in/g35rZTwb #CONNECTCommunities #CONNECTSaanich #Community #IndigenousArt #WSANEC
- GreenTree Community Inclusion Programs Inc.Recorded 27 Oct 2026
Caring for someone 12 hours a day, then going home to your kids, your homework or your second job. That's the reality for a lot of caregivers, and it's why compassion fatigue is real. At GreenTree Programs, we talk openly about burnout so our team knows they don't have to carry it alone. 💚 Explore opportunities at GreenTree Programs: https://bit.ly/4hMO1CH
Other LinkedIn formats
Watch the companies you care about.
Filter every ad by industry, country, format and network, and get alerts when a company you watch starts running new ads.